Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new 2025-12-17 entry adds a Study Status update (revision v3.3.3) to the Record History, and a prior 2025-10-31 entry removed the HHS Vulnerability Disclosure link (revision v3.3.2).SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry, v3.3.2, was added to the history. The older revision v3.2.0 was removed from the list.SummaryDifference0.1%

- Check48 days agoChange DetectedThe notice about government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check62 days agoChange DetectedAn additional Study Status entry appears in the record history (version 18) dated around 2025-10-30/31. This indicates an update to the trial’s current status.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

- Check98 days agoChange DetectedUpdate: Revision tag changed from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.